Search results
Why it's so challenging to develop vaccines for parasitic diseases
BBC News· 12 hours agoThe process of making vaccines for parasites is extremely challenging – but scientists might be on...
NIH launches 2 clinical trials testing HIV drug on women, other minority groups
UPI· 50 minutes agoJune 4 (UPI) -- The National Institutes of Health on Tuesday said they are seeking to now include...
TuHURA reports breakthrough in cancer vaccine trial By Investing.com
Investing.com· 1 day ago(NASDAQ:KTRA), has announced positive results from a Phase 1b trial of its leading cancer vaccine...
Verge Genomics CEO: Why I urge my employees to share their fears and vulnerabilities—and do the same...
Fortune via Yahoo Finance· 7 hours agoOne of my direct reports, a scientist, shared with me her sadness over her mother refusing to take...
US poised to invest millions in mRNA bird flu vaccine amid H5N1 scare
The Telegraph via Yahoo News· 5 days agoThe US government is poised to announce a multimillion-dollar investment in mRNA vaccines for H5N1...
...Enrolled in Phase II Part of Randomized Phase I/II Trial Evaluating Lead Cancer Vaccine TG4050 in...
Benzinga· 2 days agoPatient screening and enrollment are active, with the aim of enrolling 80 patients internationally in the overall Phase I/II trial.
The Push to Get More People Into Long COVID Studies
Medscape· 17 hours agoSince then, it's been a tough road for Spier, 37, who said he wouldn't wish his hellish condition on anyone. Last spring, he enrolled in a clinical trial...
Why Moderna Stock Is Sinking This Week
Motley Fool via Yahoo Finance· 5 days agoHowever, Moderna rebounded somewhat after The Financial Times reported that the U.S. government is close to finalizing a deal to fund a late-stage ...
Moderna's Options Frenzy: What You Need to Know - Moderna (NASDAQ:MRNA)
Benzinga· 6 days agoThe firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates ...
Bushwick biotech raises $7M seed round to advance genetic cancer therapy
Crain's New York Business· 1 day agoThe seed round, led by LifeSpan Vision Ventures with participation from quadraScope Ventures and other investors, will help Matter Bio move its early-stage injectable cancer ...